Biomarin Pharmaceutical (BMRN) Q2 2019 Earnings

25AprConfirmed
Q3 2018
Q4 2018
Q1 2019
Q2 2019
-0.32
-0.22
-0.12
-0.02

Details

Expected EPS
-0.21
Actual EPS
-0.32
Surprise EPS
-0.11
Surprise Percent
+52.38%

Description

Biomarin Pharmaceutical (BMRN) has reported earnings of -0.32 per share for Q2 2019.

0 Comments

Share your thoughts